<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Diversity

Research    Diversity    Magazine    Clinical Trials    COE

Cancer Clinical Trials Save Lives, and Diversity Matters

In the realm of cancer research, clinical trials can lead to more effective drugs, better treatments, and ways to prevent and detect cancer. They are a key step in the journey from scientific discoveries to helping current and future patients. Clinical trials are a major factor behind a 33% drop in the U.S. cancer death rate and an estimated 3.8 million cancer deaths avoided over the last four decades.


Author Mark Harden | Publish Date May 09, 2024
Full Story

Community    Diversity    Cancer   

Addressing Cancer Disparities Among Minorities is a Mission for the CU Cancer Center

Cancer rates are not the same for everyone – and the fact that they differ by race and ethnicity, among many other categories of people, leads to the realization that health inequity is a factor in those disparities.


Author Mark Harden | Publish Date April 01, 2024
Full Story

Diversity    Clinical Research    Inclusion    Leadership

McDermott Named Deputy AD for Diversity and Inclusion in Clinical Research at CU Cancer Center

As lead investigator or sub-investigator on numerous clinical trials at the University of Colorado Cancer Center — many of them investigating new treatments for head and neck cancerJessica McDermott, MD, has been instrumental in improving access to cancer clinical trials for patients from medically underserved communities.


Author Greg Glasgow | Publish Date October 11, 2022
Full Story

Research    Education    Students    Diversity   

Diversity in Cancer Research Program Hosts Undergraduate Students for Hands-On Experience at CU Cancer Center

For Isaiah Richardson, conducting research as an American Cancer Society Diversity in Cancer Research Intern this summer was an important academic and professional experience, but it was also personal.


Author Rachel Sauer | Publish Date August 18, 2022
Full Story

Diversity    Magazine

Director's Message: Our Commitment to Dismantling Racism

The past year has illuminated the need for change. In addition to the toll it has taken on lives, health and livelihood, COVID-19 has shed light on health disparities and inequities facing our communities of color.


Author Cancer Center | Publish Date December 03, 2020
Full Story

Pediatric Cancer    Brain and Spinal Cancer    Diversity

Post-diagnosis disparities drive poorer outcomes for pediatric Black and Hispanic brain cancer patients

Cancer researchers have known for years that Black and Hispanic patients have worse outcomes than their non-Hispanic White peers. At least when it comes to adults. But few studies have explored these same disparities in pediatric patients, and fewer still have looked for racial/ethnic differences in treatment outcomes in pediatric brain cancer patients.


Author Cancer Center | Publish Date March 12, 2020
Full Story

Lung Cancer    Diversity

African Americans, Hispanics less likely to receive recommended lung cancer imaging

The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer (NSCLC), and this accurate imaging helps to match patients with the best treatments. Unfortunately, not every NSCLC patient gets the recommended PET-CT imaging. Now a University of Colorado Cancer Center study published in the Journal of the National Cancer Institute shows an important predictor of PET-CT use: African American patients were only about half as likely as non-Hispanic whites to receive this important imaging; Hispanics received this imaging about 70 percent as frequently as non-Hispanic whites.


Author Cancer Center | Publish Date March 11, 2020
Full Story

Diversity    Cancer    Genetics

The genetic diversity that may explain differences in cancer rates across ethnicities

Paul Norman, PhD, was born in the Midlands region of Central England in the county town of Shrewsbury, which, coincidentally, is also the birthplace of the naturalist and explorer, Charles Darwin. And like Darwin, Norman set out on a mission to categorize the diversity of life. Only, while Darwin concerned himself with things he could see – the beak shape of Galapagos finches, for example – Norman explores the diversity of cells hidden inside our bodies. Even more specifically, Norman, who recently joined University of Colorado Cancer Center as a mentored member, researches the diversity of tiny proteins that sit on the surface cancer cells. What seems little could be very big: Differences in these proteins across ethnicities could help to explain the differences in cancer rates between human cultures. 


Author Cancer Center | Publish Date May 13, 2019
Full Story

CU Cancer Center In the News

Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story
Washington Post

‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.

news outletWashington Post
Publish DateJune 07, 2024

A University of Colorado team lead by James DeGregori, PhD, deputy director of the University of Colorado Cancer Center, found in an April preprint report that SARS-CoV-2 and the flu virus can cause dormant cancer cells in mice to proliferate in the lungs.

Full Story